Simvastatin displays an antioxidative effect by inhibiting an increase in the serum 8-isoprostane level in patients with acute ischemic stroke: Brief report

Clinical Neuropharmacology

Volumn 34, Issue 5, 2011, Pages 191-194

  Szczepańska Szerej, Anna ^a   Kurzepa, Jacek ^a   Wojczal, Joanna ^a   Stelmasiak, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SIMVASTATIN;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN ISCHEMIA; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; DINOPROST; FEMALE; HUMANS; MALE; MIDDLE AGED; SIMVASTATIN; STROKE; VASOCONSTRICTOR AGENTS;

EID: 80053054123     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3182309418     Document Type: Article

References (28)

1. Warlow C, Sudlow C, Dennis M, et al. Stroke. Lancet 2003;362:1211-1224. (Pubitemid 37255350)
2. Phan TG, Wright PM, Markus R, et al. Salvaging the ischemic penumbra: more than just reperfusion. Clin Exp Pharmacol Phy 2002;29:1-10. (Pubitemid 34093971)
3. Rao AV, Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci 2002;5:291-309. (Pubitemid 35174629)
4. Allen C, Bayraktutan U. Oxidative stress and its role in the pathogenesis of ischemic stroke. Int J Stroke 2009;4:461-470.
5. Chang C-Y, Chen J-Y, Ke D, et al. Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits. Nutrition 2005;21:987-993. (Pubitemid 41266989)
6. Cherubini A, Polidori MC, Bregnocchi M, et al. Antioxidant profile and early outcome in stroke patients. Stroke 2000;31:2295-2300.
7. Yamato M, Egashira T, Utsumi H. Application of in vivo ESR spectroscopy to measurement of cerebrovascular ROS generation in stroke. Free Radic Biol Med 2003;35:1619-1639.
8. Brault S, Martinez-Bermudez AK, Marrache AM, et al. Selective neuromicrovascular endothelial cell death by 8-iso-Prostaglandin F2α. Possible role in ischemic brain injury. Stroke 2003;34:776-782. (Pubitemid 36307410)
9. Zeiger S, Musiek E, Zanoni G, et al. Neurotoxic lipid peroxidation species formed by ischemic stroke increase injury. Free Radic Biol Med 2009;47:1423-1431.
10. Bergendi L, Benes L, Durackova Z, et al. Chemistry, physiology and pathology of free radicals. Life Sci 1999;65:1865-1874. (Pubitemid 29506920)
11. Atkins CM, Sweatt JD. Reactive oxygen species mediate activity-dependent neuron-glia signaling in output fibers of the hippocampus. J Neurosci 1999;19:7241-7248. (Pubitemid 29404580)
12. Hu D, Serrano F, Oury TD, et al. Aging-dependent alterations in synaptic plasticity and memory in mice that overexpress extracellular superoxide dismutase. J Neurosci 2006;26:3939-3941.
13. MCCracken E, Valeriani V, Simpson C, et al. The lipid peroxidation by-product 4-hydroxynonenal is toxic to axons and oligodendrocytes. J Cereb Blood Flow Metab 2000;20:1529-1536.
14. Adibhatla RM, Hatcher JF, Larsen EC, et al. CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: phosphocholine citydylyl-transferase after stroke. J Biol Chem 2006;281:6718-6725. (Pubitemid 43847607)
15. Darlington LG, Mackay GM, Forrest CM, et al. Altered kynurenine metabolism correlates with infarct volume in stroke. Eur J Neurosci 2007;26:2211-2221. (Pubitemid 47620487)
16. Edwards M, Rassin DK, Izumi T, et al. APE/Ref-1 responses to oxidative stress in aged rats. J Neurosci Res 1998;54:635-638. (Pubitemid 28546066)
17. Cherubini A, Ruggiero C, Polidori M, et al. Potential markers of oxidative stress in stroke. Free Radic Biol Med 2005;39:841-852.
18. Offord E, Poppel G, Tyrrel R. Markers of oxidative damage and antioxidant protection: current status and relevance to disease. Free Radic Res 2000;33:5-19.
19. Roberts LJ, Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000;28:505-513. (Pubitemid 30136031)
20. Van Kooten F, Ciabattoni G, Patrono C, et al. Platelet activation and lipid peroxidation in patients with acute ischemic stroke. Stroke 1997;28:1557-1563. (Pubitemid 27349681)
21. Sanchez-Moreno C, Dashe J, Scott T, et al. Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke 2004;35:163-168. (Pubitemid 38057613)
22. Monis M, Kane K, Schwiderski U, et al. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke 2005;36:1298-1300. (Pubitemid 40798758)
23. Nicholas J, Swearingen C, Thomas J, et al. The effect of statin pretreatment on infarct volume in ischemic stroke. Neuroepidemiology 2008;31:48-56. (Pubitemid 351957398)
24. Ejiri J, Inoue N, Tsukube T, et al. Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statins and angiotensin II type 1 receptor blocker. Cardiovasc Res 2003;59:988-996. (Pubitemid 38366255)
25. Aviram M, Rosenblat M, Bisgaier CL, et al. Atorvastatin gemfibrozyl metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation. Atherosclerosis 1998;138:271-280. (Pubitemid 28314098)
26. Nagotani S, Hayashi T, Sato K, et al. Reduction of cerebral infarction in stroke-prone spontaneously hypertensive rats by statins associated with amelioration of oxidative stress. Stroke 2005;36:670-672. (Pubitemid 40344176)
27. Kishi T, Hirooka Y, Shimokawa H, et al. Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 2008;30:3-11. (Pubitemid 351157008)
28. Sugiyama M, Ohashi M, Takase H, et al. Effects of atorvastatin on inflammation and oxidative stress. Heart Vessels 2005;20:133-136. (Pubitemid 41031009)